Cell Signaling Technology

DcR2 (D13H4) Rabbit Monoclonal Antibody

#8049 · western blot · $161,351

60
Evidence Score · Well-Established
Used by 103 independent labs across 110 papers. How we score this →
100
Citing papers
6.9k
Combined citations
Supplier page Find this product

Research areas

Cancer Mechanisms and Therapy5Autophagy in Disease and Therapy5Peptidase Inhibition and Analysis5Gut microbiota and health4Cytokine Signaling Pathways and Interactions4Cell Adhesion Molecules Research4Cancer therapeutics and mechanisms4Epigenetics and DNA Methylation4

Papers citing this product

1
Pro-oxidative activities and dose–response relationship of (−)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro
Carcinogenesis·2010·237 cit.·DOI
2
Caspase‐3‐mediated GSDME induced Pyroptosis in breast cancer cells through the ROS/JNK signalling pathway
Journal of Cellular and Molecular Medicine·2021·186 cit.·DOI
3
The Anterior Insular Cortex→Central Amygdala Glutamatergic Pathway Is Critical to Relapse after Contingency Management
Neuron·2017·160 cit.·DOI
4
A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
Oncotarget·2015·152 cit.·DOI
5
Milk Fermented by Propionibacterium freudenreichii Induces Apoptosis of HGT-1 Human Gastric Cancer Cells
PLoS ONE·2012·149 cit.·DOI
6
Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer
The Oncologist·2015·146 cit.·DOI
7
Enhanced Stem Cell Differentiation and Immunopurification of Genome Engineered Human Retinal Ganglion Cells
Stem Cells Translational Medicine·2017·144 cit.·DOI
8
TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer
Journal for ImmunoTherapy of Cancer·2021·142 cit.·DOI
9
Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1–dependent ABL1 activation in endothelial cells
The Journal of Experimental Medicine·2014·136 cit.·DOI
10
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibody
Blood·2009·128 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
DcR2 (E5X3W) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology60$161,35110

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.